Ginkgo Bioworks Holdings (DNA) Enterprise Value (2019 - 2026)
Ginkgo Bioworks Holdings posted quarterly Enterprise Value of -$143.9 million for Q1 2026, up 53.95% year-on-year from -$93.4 million in Q1 2025, and up 65.96% on a QoQ basis from -$422.6 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 8 years of Enterprise Value data on file, last reported at -$143.9 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 53.95% year-over-year to -$143.9 million; the trailing twelve-month figure through Mar 2026 stood at -$143.9 million (up 53.95% YoY), and the FY2025 full-year result was -$422.6 million, up 24.74% from the prior year.
- Enterprise Value for Q1 2026 stood at -$143.9 million, up from -$422.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$111.1 million in Q3 2025 and bottomed at -$1.5 billion in Q1 2022.
- The 5-year median for Enterprise Value is -$840.4 million (2024), against an average of -$803.9 million.
- The widest annual swing landed in 2022, when Enterprise Value plunged 470.4%; it then surged 81.98% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$1.3 billion in 2022, then rose by 28.25% to -$944.1 million in 2023, then soared by 40.52% to -$561.6 million in 2024, then increased by 24.74% to -$422.6 million in 2025, then jumped by 65.96% to -$143.9 million in 2026.
- The last three Enterprise Value figures came in at -$143.9 million (Q1 2026), -$422.6 million (Q4 2025), and -$111.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | -143.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -143.86 Mn |
| Dec 31, 2025 | -422.62 Mn |
| Sep 30, 2025 | -111.07 Mn |
| Jun 30, 2025 | -203.57 Mn |
| Mar 31, 2025 | -312.42 Mn |
| Dec 31, 2024 | -561.57 Mn |
| Sep 30, 2024 | -616.21 Mn |
| Jun 30, 2024 | -730.37 Mn |
| Mar 31, 2024 | -840.44 Mn |
| Dec 31, 2023 | -944.07 Mn |
| Sep 30, 2023 | -1.05 Bn |
| Jun 30, 2023 | -1.11 Bn |
| Mar 31, 2023 | -1.21 Bn |
| Dec 31, 2022 | -1.32 Bn |
| Sep 30, 2022 | -1.30 Bn |
| Jun 30, 2022 | -1.35 Bn |
| Mar 31, 2022 | -1.46 Bn |
| Dec 31, 2021 | -1.49 Bn |
| Sep 30, 2021 | -1.67 Bn |
| Jun 30, 2021 | -235.89 Mn |
| Mar 31, 2021 | -308.13 Mn |
| Dec 31, 2020 | -372.13 Mn |
| Sep 30, 2020 | -471.06 Mn |
| Dec 31, 2019 | -495.29 Mn |